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A number of studies have reported on associations between reproductive factors, such as
delivery methods, number of birth and breastfeeding, and incidence of cancer in children,
but systematic reviews addressing this issue to date have important limitations, and no
reviews have addressed the impact of reproductive factors on cancer over the full life course
of offspring.
Methods
We performed a comprehensive search in MEDLINE, and Embase up to January 2020 and
Web of Science up to 2018 July, including cohort studies reporting the association between
maternal reproductive factors of age at birth, birth order, number of births, delivery methods,
and breastfeeding duration and cancer in children. Teams of two reviewers independently
extracted data and assessed risk of bias. We conducted random effects meta-analyses to
estimate summary relative estimates, calculated absolute differences between those with
and without risk factors, and used the GRADE approach to evaluate the certainty of
evidence.
Results
For most exposures and most cancers, we found no suggestion of a causal relation. We
found low to very low certainty evidence of the following very small possible impact: higher
maternal age at birth with adult multiple myeloma and lifetime uterine cervix cancer
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incidence; lower maternal age at birth with childhood overall cancer mortality (RR = 1.15,
95% CI = 1.01–1.30; AR/10,000 = 1, 95% CI = 0 to 2), adult leukemia and lifetime uterine
cervix cancer incidence; higher birth order with adult melanoma, cervix uteri, corpus uteri,
thyroid cancer incidence, lifetime lung, corpus uteri, prostate, testis, sarcoma, thyroid cancer
incidence; larger number of birth with childhood brain (RR = 1.27, 95% CI = 1.06–1.52; AR/
10,000 = 1, 95% CI = 0 to 2), leukemia (RR = 2.11, 95% CI = 1.62–2.75; AR/10,000 = 9,
95% CI = 5 to 14), lymphoma (RR = 4.66, 95% CI = 1.40–15.57; AR/10,000 = 11, 95% CI =
1 to 44) incidence, adult stomach, corpus uteri cancer incidence and lung cancer mortality,
lifetime stomach, lung, uterine cervix, uterine corpus, multiple myeloma, testis cancer inci-
dence; Caesarean delivery with childhood kidney cancer incidence (RR = 1.25, 95% CI =
1.01–1.55; AR/10,000 = 0, 95% CI = 0 to 1); and breastfeeding with adult colorectal cancer
incidence.
Conclusion
Very small impacts existed between a number of reproductive factors and cancer incidence
and mortality in children and the certainty of evidence was low to very low primarily due to
observational design.
Introduction
Childhood cancer, one of the most frequent causes of death in children in developed countries,
has increased over time [1]. The range of tumor types varies across age groups with leukemia
most frequent in children aged 0 to 14 years and lymphoma in children aged 15 to 19 years [2].
Public health officials and investigators have recognized parental or family factors as possi-
ble determinants of childhood health. Many studies have reported that a variety of maternal
reproductive factors, including delivery methods, age at birth, number of births, and breast
feeding were associated with children’s adverse health outcomes [3–6]. Furthermore, scientists
have raised concern regarding maternal risk factors that can influence the health status of off-
spring in adulthood [7–10].
The underlying mechanism of cancer risk in offspring according to the maternal reproduc-
tive factors involves the development of immune system. Cesarean delivery might interfere the
development of the immune system through altering bacterial colonization or adverse birth
stress response [11]. Breastmilk could influence the immune system with many immunologi-
cally active components [12]. Possible explanation for older mother relating cancer of off-
spring include transmission of altered DNA damage response and repair pathways in oocytes
to the offspring [6].
Reproductive factors have, over the years, altered worldwide. Changes include increasing
rate of cesarean delivery [13], earlier menarche [14, 15], and older age at birth [16]. These
changes may have influenced health outcomes of children as well as mothers. Several system-
atic reviews have suggested an association between reproductive factors and cancer in children
[12, 17, 18]. However, previous reviews have contained limitations including failure to assess
the certainty of evidence [12, 18], to consider the magnitude of observed effects, or to address
the full range of reproductive factors or relevant studies: some focused on specific types of
reproductive factors [12, 19, 20], others on case-control studies [12, 17, 18], and few addressed
the possible association between maternal reproductive factors and cancer risks in adulthood.
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The purpose of this systematic review and meta-analysis was, therefore, to investigate the
relation between maternal reproductive factors and cancer risks of children including the most
recent studies reflecting women’s current reproductive behavior. Our perspective was to
address the possibility that maternal reproductive factors are causally related to cancer inci-
dence and mortality in children.
Materials and methods
We conducted and reported this review in adherence to the Preferred Reporting Items for Sys-
tematic Review and Meta-analysis statement guidelines (S1 Table) [21]. We registered the pro-
tocol of this review at PROSPERO (CRD42018112045).
Data source and search strategy
We developed a search strategy using a combination of controlled vocabulary (Mesh, Emtree
terms) and free-text words related to reproductive factors and health outcomes (S2 Table). We
performed a literature search in MEDLINE, and EMBASE from inception until January 2020
and Web of Science from inception until July 2018, consulted reference lists of included stud-
ies and systematic reviews for additional eligible studies, and made no restriction on publica-
tion period. This search is part of an effort to examine the relations between maternal
reproductive factors and various health outcomes.
Study selection
We included cohort studies with more than 1-year follow-up reporting the association
between one or more reproductive factors and one or more cancer outcomes in children.
Maternal reproductive factors included age at birth, birth order, total number of births, deliv-
ery methods and duration of breast-feeding. Cancer outcomes included total cancer incidence
and mortality and major cancer types of childhood and adulthood: overall cancer, oral, esoph-
agus, stomach, colorectum, liver, pancreas, larynx, lung, melanoma of skin, female breast, cer-
vix uteri, corpus uteri, ovary, prostate, testis, kidney, urinary bladder, thyroid, brain and
central nervous system, multiple myeloma, leukemia, lymphoma, eye, bone, and connective
and soft tissue cancer.
Studies typically did not report associations with birth order, but if studies reported associa-
tions between number of older siblings or parity at birth and cancer, we inferred birth order
from this information. Studies typically did not report associations with the total number of
births, but if studies reported associations between the total number of children or siblings and
cancer, we regarded them as the total number of births.
We excluded studies addressing associations between specific maternal health conditions
(e.g., children born to mother with human immunodeficiency virus) and cancer, as well as
reviews, case reports, or conference abstracts.
Eligibility ascertainment and data extraction
Teams of two reviewers independently screened titles and abstracts of studies identified using
the search strategy for potential eligibility, obtained full texts of any article that either reviewer
believed might be eligible, and evaluated each full-text article for potential eligibility. Reviewers
resolved disagreement by discussion or, if necessary, through adjudication by a third reviewer.
After calibration exercises to ensure validity and consistency, teams of two reviewers using
pre-piloted extraction forms, independently extracted the following information from eligible
studies: first author, publication year, country of origin, name of cohort; number of study
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participants, their age, gender, type and classification of reproductive factors; and cancer out-
comes [type of cancer, age at assessment, follow-up period, effect estimates with corresponding
95% confidence interval (CI)]. Reviewers resolved disagreements by discussion or, if necessary,
through adjudication by a third reviewer.
Risk of bias
Teams of two reviewers independently assessed risk of bias using a modified version of the
Quality in Prognostic Studies instrument with the following five items: (1) Study participation,
(2) Study attrition, (3) Reproductive factor measurement, (4) Outcome measurement, and (5)
Confounding [22]. Reviewers rated each item as low, moderate, or high risk and overall risk of
bias as high if two or more items proved to be at a high risk of bias. Reviewers resolved dis-
agreements through discussion or, if necessary, by adjudication form a third reviewer. S3
Table presents the instrument and the associated detailed guidance.
Analysis
We performed meta-analyses, calculating summary relative effects of each reproductive factor
on cancer incidence or mortality of children using the DerSimonian-Laird random-effects
model. We visualized heterogeneity with forest plots and tested with I2 values and Q statistics.
We performed statistical analyses using the R software 3.5.1 (the R foundation).
For maternal age at birth, we calculated pooled relative effects for highest and lowest age
compared to 24 to 29 years. If a study did not explicitly consider an age category of 24 to 29,
we chose the closest age category as the reference. We used age at birth between 24 to 29 years
old as the reference group because it has been, over the past few decades, the most frequent age
group of births in many countries [23] and many consider this as the optimal age of birth [24].
For birth order, total number of births, and duration of breastfeeding, we compared highest
versus lowest categories. For delivery method, we calculated pooled relative effects comparing
Cesarean with vaginal delivery.
For studies in which authors treated exposure as a continuous variable and did not present
categorical analysis, we converted the relative effects estimate to correspond to a 10-year differ-
ence for maternal age at childbirth, 3 order difference for birth order, 3 degree difference for
number of childbirths, in each case the most often reported difference, and used these in our
meta-analyses.
We pooled risk estimates according to the life course of offspring based on when the out-
comes were measured: childhood, adulthood, and lifetime. We classified the outcomes as
childhood if a study assessed outcomes between 0 to 19 years, adulthood if a study assessed
outcome 20 or more years and lifetime if a study assessed outcome in both childhood and
adulthood. We could not calculate pooled estimates across lifetime due to the small number of
eligible studies.
We conducted a priori specified meta-regression to test for differences between studies at
higher versus lower risk of bias. We had planned to perform the Hartung-Knapp (HK) ran-
dom meta-analysis as a sensitivity analysis and also planned to conduct subgroup analyses on
income level of countries, and order of publication. However, we could not complete these
additional analyses due to the small number of included studies.
Certainty of evidence
We assessed certainty of evidence taking a causal perspective for each cancer risk using the
Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach
that uses four certainty categories (very low, low, moderate or high) [25]. One investigator
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assessed the certainty of evidence and a second investigator revised the certainty assessments
as necessary. The GRADE approach to rating the certainty of evidence begins with the study
design and then addresses five reasons to possibly rate down the certainty of evidence (risk of
bias, imprecision, inconsistency of results, indirectness of evidence and publication bias) and
three (including large magnitude of effect and dose-response gradient) to possibly rate up the
certainty. When assessing causation, in the GRADE approach, randomized controlled trials
(RCTs) start as high certainty evidence, while observational studies starts as low certainty evi-
dence. If reasons for rating up are present (as in, for example, smoking as a causal exposure in
lung cancer) certainty of evidence from observational studies can yield moderate or even high
certainty evidence. We calculated absolute risk difference by multiplying relative effect and
population risk of cancer, produced by the International Agency Research on Cancer (IARC)
to estimate population cancer risks. IARC provided 5-year interval cumulative risk of cancer
incidence or mortality using online analysis systems, we chose the median cumulative cancer
risk among countries for 0 to 19 for childhood and for 20 to 74 for adulthood [26, 27]. For life-
time cancer risk, we used GLOBOCAN 2018 estimates of cumulative risk from 0 to 74 [28].
We presented summary of finding tables and stated plain language summary based on absolute
effect magnitude and certainty of evidence [29].
Results
Study selection and characteristics of included studies
We identified 43 eligible studies including 24 cohorts enrolling more than 38 million partici-
pants (Fig 1, S4 Table) [7–10, 30–68]. Of these, 8 articles reported on overall cancer incidence,
2 on esophagus, 4 on stomach, 7 on colorectum, 4 on liver, 3 on pancreas, 1 on larynx, 4 on
lung, 6 on melanoma, 11 on breast, 4 on cervix uteri, 5 on corpus uteri, 3 on ovary, 5 on pros-
tate, 9 on testis, 8 on kidney, 2 on bladder, 3 on thyroid, 9 on brain, 3 on multiple myeloma, 14
on leukemia, 12 on lymphoma, 4 on eye, 4 on bone, 3 on connective and soft tissue cancer inci-
dence. We also identified 3 articles reporting overall cancer mortality, 2 on stomach, 1 on col-
orectum, 1 on liver, 1 on lung, 2 on breast, 1 on prostate, 1 on brain, 1 on leukemia, 1 on
lymphoma, 1 on eye, 1 on bone, and 1 on connective and soft tissue cancer mortality.
Of the eligible reports addressing cancer incidence, all addressing, liver, larynx, cervix uteri,
kidney, bladder, thyroid, brain, multiple myeloma, leukemia, eye, bone, and connective and
soft tissue cancer were at low risk of bias. This was also true of 1/2 on esophagus, 3/4 on stom-
ach, 6/7 on colorectum, 2/3 on pancreas, 3/4 on lung, 5/6 on melanoma, 5/11 on breast, 4/5 on
corpus uteri, 2/3 on ovary, 4/5 on prostate, 8/9 on testis cancer incidence and 11/12 on lym-
phoma. Of the eligible reports addressing cancer mortality, the following were all at low risk of
bias: overall, colorectum, liver, prostate, brain, leukemia, lymphoma, eye, bone and soft tissue,
as were 1/2 on stomach, 0/1 on lung, and 1/2 on breast cancer (S5 Table).
Maternal reproductive factors and childhood cancer incidence and
mortality
Table 1 presents the results for maternal reproductive factors in which we found an apparent
impact [95% CI around relative risk (RR) excludes 1.0] on childhood cancer. These include
lower maternal age at birth compared to 25 to 29 maternal age at birth and overall cancer mor-
tality (RR = 1.15, 95% CI = 1.01–1.30; AR/10,000 = 1, 95% CI = 0 to 2; low certainty); a larger
number of births and childhood brain cancer (RR = 1.27, 95% CI = 1.06–1.52; AR/10,000 = 1,
95% CI = 0 to 2; low certainty), leukemia (RR = 2.11, 95% CI = 1.62–2.75; AR/10,000 = 9, 95%
CI = 5 to 14; low certainty) and lymphoma incidence (RR = 4.66, 95% CI = 1.40–15.57; AR/
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10,000 = 11, 95% CI = 1 to 44; very low certainty) compared to a smaller number of births.
Compared to vaginal delivery, Caesarean delivery was associated with childhood kidney cancer
incidence (RR = 1.25, 95% CI = 1.01–1.55; AR/10,000 = 0, 95% CI = 0 to 1; low certainty). The
absolute magnitude of apparent impact in each case was very small: from 0 in 10,000 to 11 in
10,000. S6 Table presents the more frequent results: failure to establish an apparent impact of
reproductive factors on cancer incidence or mortality (i.e. 95% CI around RR overlapping
1.0). S7 Table presents further details of results.
Fig 1. Search and selection of studies.
https://doi.org/10.1371/journal.pone.0230721.g001
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Maternal reproductive factors and adult cancer incidence and mortality
Table 2 presents the results for maternal reproductive factors in which we found an apparent
impact (95% CI around RR excludes 1.0) on cancer during adulthood. These include higher
maternal age at birth with adult multiple myeloma incidence (very low certainty); lower mater-
nal age at birth compared to 25 to 29 age at birth with adult leukemia incidence (very low cer-
tainty); higher birth order with on adult melanoma (low certainty), cervix uteri (low
certainty), corpus uteri (low certainty), and thyroid (low certainty) cancer incidence compared
to lower birth order; larger number of births with adult stomach (low certainty), corpus uteri
(low certainty) cancer incidence and lung cancer mortality (very low certainty). The absolute
magnitude of apparent impact in each case was very small: from 3 in 1,000 to 21 in 1,000. S8
Table presents the more frequent results: failure to establish an apparent impact of reproduc-
tive factors on cancer incidence or mortality (i.e. 95% CI around RR overlapping 1.0). S9 Table
presents additional detailed results.
Maternal reproductive factors and lifetime cancer incidence and mortality
Table 3 presents the results for maternal reproductive factors in which we found an apparent
impact (95% CI around RR excludes 1.0) on lifetime cancer incidence. These include higher
maternal age at birth with uterine cervix cancer incidence (low certainty); lower maternal age
compared to 25 to 29 age at birth with uterine cervix cancer incidence (low certainty); higher
birth order compared to lower birth order with increase in lung (low certainty), corpus uteri
(low certainty), prostate (low certainty), testis (low certainty), connective and soft tissue (low
certainty), thyroid (low certainty) cancer incidence; more compared to fewer number of births
with stomach (low certainty), lung (low certainty), melanoma (low certainty), uterine cervix
(low certainty), uterine corpus (low certainty), multiple myeloma (low certainty), and testis












Certainty of the evidence Plain language summary
Lower maternal age at birth compared to 25 to 29 maternal age
Overall cancer
mortality (1)
1114/NR, Mean 6.6 1.15 (1.01–
1.30)
6 1 more (0 fewer
to 2 more)
LOW (due to observational
design)
Lower maternal age at birth may
have little or no effect on overall
cancer mortality




424/NR, Up to 14 1.27 (1.06–
1.52)
4 1 more (0 fewer
to 2 more)
LOW (due to observational
design)
Higher number of births may have




306/NR, Up to 15 2.11 (1.62–
2.75)
8 9 more (5 more
to 14 more)
LOW (due to observational
design)
Higher number of births may result




13/NR, Mean 14.9 4.66 (1.40–
15.57)
3 11 more (1 more
to 44 more)
VERY LOW (due to
observational design,
imprecision) b
We are uncertain of the effects of
higher number of births on
lymphoma incidence







1 0 fewer (0 fewer
to 1 more)
LOW (due to observational
design)
Cesarean delivery may have little or
no effect on kidney cancer
incidence
CI, Confidence Interval; CNS, Central Nervous System; NR, Not Reported
a Cumulative risk between 0 to 19 years from the International Agency Research on Cancer online analysis system.
b Confidence interval around absolute effect includes both no appreciable effect and appreciable harm.
https://doi.org/10.1371/journal.pone.0230721.t001
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(low certainty) cancer incidence. The absolute magnitude of apparent impact in each case was
very small: from 0 in 1,000 to 14 in 1,000. S10 Table presents the more frequent results: failure
to establish an apparent impact of reproductive factors on cancer incidence or mortality (i.e.
95% CI around RR overlapping 1.0). S11 Table presents further detailed results.
Discussion
We found evidence of a number of associations between maternal reproductive factors and
cancer incidence and mortality in children: higher maternal age at birth with adult multiple
myeloma and lifetime uterine cervix cancer incidence; lower maternal age at birth with












Certainty of the evidence Plain language summary




37/NR, Mean 11 4.53 (1.35–
15.16)
4 14 more (1
more to 56
more)
VERY LOW (due to
observational design,
imprecision) b
We are uncertain of the effects of
higher maternal age at birth on
multiple myeloma incidence
Lower maternal age at birth compared to 25 to 29 maternal age
Leukemia
incidence (1)
47/NR, Mean 11 2.08 (1.05–
4.12)
6 6 more (0 fewer
to 19 more)
VERY LOW (due to
observational design,
imprecision) b
We are uncertain of the effects of
higher maternal age at birth on
leukemia incidence







10 3 fewer (5 fewer
to 2 fewer)
LOW (due to observational
design)
Higher birth order may result in a









7 3 fewer (4 fewer
to 1 fewer)
LOW (due to observational
design)
Higher birth order may result in a









16 5 fewer (7 fewer
to 4 fewer)
LOW (due to observational
design)
Higher birth order may result in a








6 3 fewer (4 fewer
to 1 fewer)
LOW (due to observational
design)
Higher birth order may result in a
very small decrease on thyroid cancer
incidence







7 4 more (0 fewer
to 10 more)
LOW (due to observational
design)
Higher number of births may have









16 8 fewer (10
fewer to 7
fewer)
LOW (due to observational
design)
Higher number of births may result




67/1,272, Up to 25 2.18 (1.05–
4.52)
18 21 more (1
more to 63
more)
VERY LOW (due to
observational design, risk of
bias, imprecision) b
We are uncertain of the effects of
higher number of births on lung
cancer mortality







20 4 more (2 more
to 5 more)
VERY LOW (due to
observational design, risk of
bias) c
We are uncertain of the effects of
breastfeeding on colorectal cancer
incidence
CI, confidence interval; NR, not reported
a Cumulative risk between 20 to 74 years the International Agency Research on Cancer online analysis system.
b Confidence interval around absolute effect includes both no appreciable effect and appreciable harm.
c Study at high risk of bias for inappropriate measurement of reproductive factor and inadequate adjustment for confounders
https://doi.org/10.1371/journal.pone.0230721.t002
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Higher maternal age at birth compared to 25 to 29 maternal age
Uterine cervix cancer
incidence (2)









Higher maternal age at birth may result
in a very small decrease in uterine
cervix cancer incidence












Lower maternal age at birth may result
in a very small increase in cervix
cancer incidence












Higher birth order may result in a very
small increase in lung cancer incidence
Corpus uteri cancer
incidence (1)
NR/NR, Up to 46 0.60 (0.46–
0.78)





Higher birth order may result in a very




NR/NR, Up to 46 1.38 (1.23–
1.55)





Higher birth order may result in a very













Higher birth order may have little or












Higher birth order may result in a very














Higher birth order may have little or
no effect on connective and soft tissue
cancer incidence
Higher number of births compared to smaller number of births
Stomach cancer
incidence (1)
946/NR, Up to 46 1.48 (1.31–
1.67)





Higher number of births may result in




3206/NR, Up to 46 1.13 (1.02–
1.25)





Higher number of births may result in




3630/NR, Up to 46 0.72 (0.65–
0.79)





Higher number of births may result in




1450/NR, Up to 46 1.19 (1.08–
1.31)





Higher number of births may result in




1858/NR, Up to 46 0.76 (0.70–
0.82)





Higher number of births may result in













Higher number of births may have




680/NR, Up to 45 1.34 (1.08–
1.66)





Higher number of births may have
little or no effect on multiple myeloma
incidence
CI, confidence interval; NR, not reported
a Lifetime cumulative risk from Globocan 2018 statistics (Farley et al., 2019).
https://doi.org/10.1371/journal.pone.0230721.t003
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childhood overall cancer mortality, adult leukemia and lifetime uterine cervix cancer inci-
dence; higher birth order with adult melanoma, cervix uteri, corpus uteri, thyroid cancer inci-
dence, lifetime lung, corpus uteri, prostate, testis, connective and soft tissue, thyroid cancer
incidence; larger number of births with childhood brain, leukemia, lymphoma incidence,
adult stomach, corpus uteri cancer incidence and lung cancer mortality, lifetime stomach,
lung, uterine cervix, uterine corpus, multiple myeloma, testis cancer incidence; and Caesarean
delivery with childhood kidney cancer incidence. As presented in Tables 1 to 3, the magnitude
of the apparent effects in absolute terms was, however, very small. Further, the certainty of the
evidence in terms of establishing a causal relation between exposure and outcomes was low or
very low.
The strengths of this review included our decision to focus on causation, and our use of
GRADE assessment for the certainty of evidence. Moreover, we calculated the magnitude of
the effects not only with relative, but also with absolute effects. Teams of two reviewers judged
eligibility and independently extracted data and assessed risk of bias utilizing, if needed, third
party adjudication. We conducted the analyses according to the developmental period of off-
spring, presenting results from both childhood and from adulthood. This provided a compre-
hensive picture of the associations between maternal reproductive factors on cancer risks of
children throughout their lives.
Turning to limitations, our review was based on observational studies that provided only
low or very low certainty evidence for causation. Although RCTs could provide a high cer-
tainty of evidence for causality, the nature of the exposures of interest makes RCTs unfeasible
or unethical or practical reasons, except for highly specific situations such as Caesarean section
delivery for breech presentation [69] or promotion programs for breast feeding [70].
We had planned to perform the Hartung-Knapp (HK) random meta-analysis as a sensitiv-
ity analysis but could not present due to a small number of studies included [71, 72]. Also, we
could not perform prior planned subgroup analysis such as income level of countries or order
of publication due to the small number of eligible studies.
Some previous studies reported differential effects of cancer subtype according to maternal
reproductive factors such as maternal age effects for childhood lymphoblastic vs myeloid leu-
kemia [33], or sibship size and Hodgkin vs non-Hodgkin lymphoma [57]. Our failure to plan
and conduct analyses for the cancer subtype therefore represents a limitation of our work.
Most eligible studies used existing databases, such as birth registries that provided represen-
tative and nearly complete data for the target population with limited risk for selection and
attrition bias. Sometimes registers contained only limited confounder information and pri-
mary studies could, as a result, not address some important confounders [73]. Because regis-
try-based studies often have great statistical power to detect small effects, they may highlight
unimportant effects. We dealt with this issue by calculating and presenting absolute as well as
relative risks. In doing so, we found that the magnitude of any possible impact of reproductive
factors on cancer was extremely small.
Our results are consistent with previous reviews addressing the association between mater-
nal reproductive factors and offspring’s cancer risk with regard to relative risks. However, the
majority of previous reviews focused on case-control studies [12, 18] that are at a higher risk of
bias than cohort studies [74, 75]. For case-control studies, differential ascertainment of expo-
sure and outcomes in cases and controls could cause bias. Nested-case control could measure
variables in the same way as cohort studies and, when performed appropriately, thus prevent
differential assessment. They remain vulnerable, however, to differential participation due to
their procedure for selecting cases and controls from the defined cohort. Although the studies
included in this review also relied on exposure information reported by mothers or fathers, dif-
ferential recall bias is likely to be far less in cohort studies that address exposure before
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outcomes occur [45, 64]. Cohort studies also provide the most representative results of the
population of interest.
Prior investigators have not, as our review has done (Tables 2 and 3 and S8 and S10 Tables)
summarized the effect of maternal reproductive factors on cancer risk according to the life
course of offspring. Moreover, prior reviews did not address possible absolute impact of repro-
ductive factors on cancer incidence and mortality.
Had we addressed association alone, our certainty of evidence would have been in most
cases high to moderate. We chose, however, to address possible causal relationships, and the
possibility of residual confounding in observational studies limits inferences regarding causa-
tion. For instance, even when associations exist, they may be due not to the maternal repro-
ductive factors, but other factors such as socioeconomic status and maternal education that are
themselves associated with maternal reproductive factors. Were this the case, modification of
reproductive factors, even when associated with cancer outcomes, would have no impact on
those outcomes. Our GRADE ratings of low to very low certainty evidence reflect our goal of
addressing causation.
Conclusion
Thus, low to very low certainty of evidence suggests a causal link between a number of mater-
nal reproductive factors and several types of cancer in offspring. Even were decision makers
prepared to suggest public health initiatives to modify cancer risk on the basis of low to very
low certainty evidence of causation, however, our results would provide only a very limited
rationale for such action. The reason is that the magnitude of any absolute effects of the expo-
sure was small to very small. Public health decision makers interested in reducing cancer in
children–either during childhood or adulthood–should, therefore, focus on areas other than
maternal reproductive factors.
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